Embo Medical, emanating from the first year of BioInnovate was established by fellows Wayne Allen, Colin Forde and Liam Mullins to develop the first true one-shot vascular embolisation device. Embo Medical raised €3 million in investment to further develop the product towards commercialisation. The investment syndicate included the AIBSeed Capital Fund, Irrus Investments and the Halo Business Angel Network. The venture was also supported by Enterprise Ireland under its high potential start-up fund following an initial Commercialisation Fund award. Embo Medical sold to Bard Clearstream in 2015 for a total of €43.5 million.

  • Established: 2012
  • Funding: €3 million
  • Status: Sold to Bard Clearstream for €35.58 million


Our Location

Situated on the prestigious campus of National University of Ireland Galway within the medieval city of Galway, European Capital of Culture in 2020, with equal easy access to the wilderness of Connemara in the west and the European mainland in the east, BioInnovate boasts a superb location.

Our affiliation with Stanford BioDesign has helped us to become one of the world’s leading innovation hubs with an immense debt of gratitude owed to Enterprise Ireland for both their financial and professional support in helping BioInnovate grow.

Contact Us Today
BioInnovate Ireland Block E
National University of Ireland Galway,
Ireland +353 (0)91 492 646